Trial Profile
Effect of low dose infliximab in patients with moderate to severe ulcerative colitis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 13 May 2016 New trial record